Gaucher’s drug approved
(Thanks to Israel21c and Globes) Elelyso – a new treatment for Gaucher’s disease, from Israel’s Protalix BioTherapeutics, is set to hit pharmacies around the globe, following approval by the American Food and Drug Administration. The drug has been licensed to Pfizer.
Israeli surgeons save pregnant Cypriot woman
In a 48-hour operation, doctors at Jerusalem’s Hadassah hospital saved the life of a 30-year old woman from Cyprus suffering from an ectopic pregnancy. Her non-viable foetus was discovered behind a kidney and had already damaged blood vessels, causing major bleeding.
Ukranian wakes from coma in Israeli hospital
25-year-old yeshiva student, Aharon Alexander Goncharov, had been in a coma after he was beaten up in Kiev on the second night of Passover. Following surgery, Goncharov defied all odds and regained consciousness two weeks later, in Tel Aviv’s Sourasky (Ichilov) Medical Centre. "I got my life back only because you all prayed for me," he said to his many well-wishers.
The first international medical devices summit
Tel Aviv’s MEDinISRAEL June summit will focus on the Asia-Pacific region. It will feature hospital care equipment, diagnostics, monitoring, rehabilitation solutions and technologies for personalised medicine of the future.
An innovation in caring
ALEH is Israel’s largest network of residential facilities for children with severe physical and cognitive disabilities. It provides over 650 children from around Israel with high-level medical and rehabilitative care to help them reach their greatest potentials. ALEH is celebrating its 30th anniversary.
Immunity research requires the Midas touch
(Thanks to Israel21c) Tel Aviv University scientists have developed a new method of prompting the immune system to create protective antibodies. Using nano-particles made of pure gold, the immune system responds when they are coated with different chemical residues.
Scientists search for the Peres gene
Galilee Genetics Analysis (GGA) Laboratories in the Golan has taken a sample of DNA from the saliva of Israeli President Shimon Peres to try to find out the secret of his longevity and mental clarity.
Let’s collaborate
A new open-access online medical journal seeks to promote intellectual interactions between scholars in Israel and abroad. All work on the journal (including editing and peer reviews) is voluntary and unpaid. It will deal with all aspects of health care and aims to help develop health policy globally.
Nausea drug success
Israel’s Redhill Biopharma announced success in Phase III trials of RHB-102 – a once-a-day pill for the prevention of nausea in cancer patients. Redhill now plans to apply to the US Food and Drug Administration for a pre-New Drug Application (NDA) hearing for marketing approval for RHB-102.
Effective treatment for depression
Brainsway’s Deep TMS (transcranial magnetic stimulation) device can make a significant improvement to those suffering from severe depression. In trials on 250 patients, 30.4% of the patients treated with Deep TMS achieved remission, compared with 14.5% of the control group.